Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug‐Eluting Stent Implantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1522-726x|88|3|350-357

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.88, Iss.3, 2016-09, pp. : 350-357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

“Full Metal Jacket” Drug‐Eluting Stent Implantation

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1051-1052

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessment of Characteristics of Neointimal Hyperplasia after Drug-Eluting Stent Implantation in Patients with Diabetes Mellitus: An Optical Coherence Tomography Analysis

By  

Cardiology, Vol. 128, Iss. 1, 2014-02 ,pp. : 34-40

Karger

Access to resources Recommend Favorite

Glycosylated Hemoglobin Is a Predictor of Major Adverse Cardiac Events after Drug-Eluting Stent Implantation in Patients with Diabetes Mellitus

By  

Cardiology, Vol. 116, Iss. 1, 2010-05 ,pp. : 51-57

Karger

Access to resources Recommend Favorite

Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug‐eluting stent

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. S1, 2015-03 ,pp. : 696-705

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early healing assessment with optical coherence tomography of everolimus‐eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 88, Iss. 3, 2016-09 ,pp. : E67-E73

John Wiley & Sons Inc

Access to resources Recommend Favorite